|
|||
|
Please join us as we celebrate the generosity of the Mogford Campbell family and the appointment of Dr. James Dowling as the inaugural Mogford Campbell Chair in Paediatric Clinical Neuroscience.
The creation of this Chair is yet another example of the dedication of the Mogford Campbell family to making a big difference in the lives of the littlest patients. This gift ensures that SickKids will remain a leader in the research and treatment of neurological conditions in newborns and infants to prevent conditions that affect their quality of life long-term. Building upon SickKids inter-disciplinary research strengths to treat newborns' nervous systems within the crucial window of development, leading the training of next generation health-care providers and clinician-scientists to build capacity, and providing the guidance to bring a variety of experts together, this Chair will deliver a leading-edge research program and ensure new discoveries are translated into clinical practice as quickly as possible to provide best-in-class care for children and their families. Dr. Dowling is a staff clinician in the Division of Neurology and a senior scientist in Genetics and Genome Biology at the Hospital for Sick Children in Toronto, Canada. He received his BS and MS from Yale University and his MD/PhD from University of Chicago. His PhD was performed in the laboratory of Elaine Fuchs. He did his child neurology training at Children's Hospital of Philadelphia, followed by a postdoctoral fellowship in neuromuscular diseases at the University of Michigan. He was an assistant professor at the University of Michigan until moving to Toronto, where he is now an associate professor in paediatrics and molecular genetics at the University of Toronto. Dr. Dowling's clinical expertise is in congenital myopathies, and he is one of the leading authorities on the diagnosis, care, and treatment of these disorders. His research examines disease pathogenesis and therapy development for congenital myopathies, with a particular focus on nemaline myopathy and centronuclear myopathy. His laboratory has helped pioneer the use of the zebrafish as a congenital myopathy disease model, and he is exploring multiple avenues for developing treatments for these conditions. |
|||
|
|||
|